Brian C Callaghan, MD, MS
Neurology
109 Zina Pitcher Pl, 4021 BSRB
Ann Arbor, Michgan 48109-2200
Manage Your Profile
About
Dr. Callaghan is a Professor of Neurology and a neuromuscular specialist at the University of Michigan. He completed his medical degree and neurology residency at the University of Pennsylvania and completed a fellowship in neuromuscular disease at the University of Michigan. He also completed a master’s degree program in clinical research at the University of Michigan School of Public Health.
Qualifications
-
FellowshipCenter for Healthcare Research and Transformation Policy, University of Michigan, Ann Arbor, Michigan, United States
2016 - 2016
Postdoctoral Fellowship
-
FellowshipUniversity of Michigan Health System, Neuromuscular, Ann Arbor, Michigan, United States
2008 - 2009
Postdoctoral Fellowship
-
ResidencyUniversity of Pennsylvania Medical Center, Neurology, Philadelphia, Pennsylvania, United States
2005 - 2008
Residency
-
Internship, Preliminary MedicineUniversity of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
2004 - 2005
Internship
-
MSUniversity of Michigan, Ann Arbor, Michigan, United States
2009 - 2011
-
MDUniversity of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, Pennsylvania, 19104, United States
2000 - 2004
-
BSUniversity of Michigan, Ann Arbor, Michigan, United States
1996 - 1999
Center Memberships
-
Center MemberOpioid Research Institute
-
Center MemberCaswell Diabetes Institute
-
Center MemberInstitute for Healthcare Policy and Innovation
Research Overview
Dr. Callaghan is interested in the treatment of painful diabetic neuropathy and other chronic pain conditions including the role of opioids. He has led the recent American Academy of Neurology guideline on the treatment of painful diabetic neuropathy and is interested in better understanding the best interventions for this common condition. Furthermore, Dr. Callaghan is interested in a better understanding of the appropriate role of opioids in chronic non cancer pain conditions.
Recent Publications
-
Reynolds EL, Watanabe M, Banerjee M, Chant E, Villegas-Umana E, Elafros MA, Gardner TW, Pop-Busui R, Pennathur S, Feldman EL, Callaghan BC. Diabetologia, 2023 Jul 1; 66 (7): 1192 - 1207.Journal ArticleThe effect of surgical weight loss on diabetes complications in individuals with class II/III obesity
DOI:10.1007/s00125-023-05899-3 PMID: 36917280 -
Reynolds EL, Elafros MA, Muthukumar L, Shippey E, Budhu JA, Terman SW, Burke JF, Callaghan BC. Neurology, 2026 Nov 10; 107 (9): 1 - 15.Journal ArticlePredictors of Antiamyloid Medication Utilization and Adherence Among People With Alzheimer Disease and Mild Cognitive Impairment
DOI:10.1212/WNL.0000000000218594 PMID: 42879726 -
Makinson CH, Park J, Feldman EL, Callaghan BC, Reynolds EL. Diabetes, Obesity and Metabolism, 2026 Sep 16;Journal ArticleLongitudinal Metabolic Risk Factors Are Associated With Microvascular Complications
DOI:10.1111/dom.71338 -
Damilola A, Makinson C, Elafros MA, Mizokami-Stout K, Feldman EL, Callaghan BC, Reynolds EL. Diabetic Medicine, 2026 Sep 16;Journal ArticleThe effect of social determinants of health on use of diabetes-related mobile health applications in older adults with type 2 diabetes
DOI:10.111/dme.70464 -
Heaton N, Reynolds EL, Koenig F, Muthukumar L, Huijg M, Taams NE, van Doorn PA, Callaghan BC. Journal of the Peripheral Nervous System, 2026 Sep 1; 31 (3):Journal ArticleComparing the Diagnostic Characteristics of Neuropathy Questionnaires in Adults With Obesity
DOI:10.1111/jns.70163 PMID: 42629177 -
Wiggers A, Muthukumar L, Reynolds EL, Nilsson M, Hansen CS, Rungby J, Feldman EL, Callaghan BC. Diabetes Research and Clinical Practice, 2026 Sep 1; 239:Journal ArticleImpact of modifiable risk factors, including diabetes, and diabetes-related complications, on dementia risk in older U.S. adults: mutually adjusted estimates from a population-based cohort
DOI:10.1016/j.diabres.2026.113457 PMID: 42486408 -
Park J, Koubek EJ, Beare R, Ang L, Callaghan BC, Pop-Busui R, Feldman EL, Reynolds EL. Annals of Clinical and Translational Neurology, 2026 Sep 1; 13 (9): 1937 - 1946.Journal ArticleMetabolic and Microvascular Risk Factors Associated With Brain Health in Type 1 Diabetes
DOI:10.1002/acn3.70428 PMID: 42117336 -
Taams NE, Huijg M, Vermeij FH, Kuitwaard K, Hanewinckel R, de Beukelaar J, Reynolds EL, Callaghan BC, Ikram MA, van Doorn PA. Journal of the Peripheral Nervous System, 2026 Sep 1; 31 (3):Journal ArticleThe Erasmus—Polyneuropathy Symptom Score for the Screening of Chronic Axonal Polyneuropathy: A Validation Study
DOI:10.1111/jns.70143 PMID: 42442712
Featured News & Stories
Who gets Alzheimer’s drugs? Race, vulnerability and health status shape access
Who gets Alzheimer's drugs? Race, vulnerability and health status shape access
Who uses mobile apps for diabetes?
'We Cannot Distinguish Fake From Real': What We Heard This Week
Gray Areas: Realistic Possibility of Reversing Diabetic Neuropathy